Beijing Kawin Technology Share-Holding Co., Ltd.
SHH: 688687.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Desheng Zhou
- Employees
- 584
- Headquarters
- Beijing, China
- IPO year
- 2021
- Market cap
- CN¥3.4B
- Website
- https://www.kawin.com.cn
Loading 688687…
Loading profile data…Frequently asked questions about 688687
What does Beijing Kawin Technology Share-Holding Co., Ltd. (688687.SS) do?
Beijing Kawin Technology Share-Holding Co., Ltd. engages in the development and production of pharmaceutical products primarily in the areas of liver diseases in China. The company's products include recombinant human interferon alfa-2b injection and compound glycyrrhizin. It provides active pharmaceutical ingredients; clinical research services...
Where does 688687.SS trade?
Beijing Kawin Technology Share-Holding Co., Ltd. (688687.SS) trades on the Shanghai Stock Exchange.
What sector is 688687.SS in?
Beijing Kawin Technology Share-Holding Co., Ltd. (688687.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Beijing Kawin Technology Share-Holding Co., Ltd.?
Desheng Zhou is the chief executive officer of Beijing Kawin Technology Share-Holding Co., Ltd. (688687.SS).
Where is Beijing Kawin Technology Share-Holding Co., Ltd. headquartered?
Beijing Kawin Technology Share-Holding Co., Ltd. is headquartered in China.
Does 688687.SS pay a dividend?
Yes — Beijing Kawin Technology Share-Holding Co., Ltd. (688687.SS) paid a trailing twelve-month dividend of CNY 0.30 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688687.SS go public?
Beijing Kawin Technology Share-Holding Co., Ltd. (688687.SS) completed its initial public offering in 2021.